Drug profile · INN
metformin hydrochloride, sitagliptin phosphate
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
metformin hydrochloride, sitagliptin phosphate (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: film coated. Current US regulatory status: approved.
Drug details — metformin hydrochloride, sitagliptin phosphate
- US status
- approved
- Class
- —
- Route
- FILM COATED
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
metformin hydrochloride, sitagliptin phosphate (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: film coated. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is metformin hydrochloride, sitagliptin phosphate?
metformin hydrochloride, sitagliptin phosphate (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: film coated. Current US regulatory status: approved.
What is the brand name for metformin hydrochloride, sitagliptin phosphate?
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE is a marketed brand name for metformin hydrochloride, sitagliptin phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of metformin hydrochloride, sitagliptin phosphate?
metformin hydrochloride, sitagliptin phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.